share_log

Leap Therapeutics Provides Update on BeiGene Option Agreement For DKN-01; Says BeiGene's Option Under Exclusive Option And License Agreement Has Expired

Leap Therapeutics Provides Update on BeiGene Option Agreement For DKN-01; Says BeiGene's Option Under Exclusive Option And License Agreement Has Expired

Leap 治療為 DKN-01 提供百濟神州期權協議的最新信息;百濟神州的獨家選項和許可協議下的選項已經過期
Benzinga ·  2023/03/16 16:16

Leap Therapeutics Provides Update on BeiGene Option Agreement For DKN-01; Says BeiGene's Option Under Exclusive Option And License Agreement Has Expired

Leap 治療為 DKN-01 提供百濟神州期權協議的最新信息;百濟神州的獨家選項和許可協議下的選項已經過期

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論